What is Current Health?
Current Health operates at the intersection of healthcare technology and medical informatics, providing a sophisticated platform designed for continuous patient monitoring. By integrating hardware and software solutions, the company enables healthcare providers to track patient vitals in real-time, facilitating proactive clinical interventions and reducing hospital readmission rates. Its market position is defined by its ability to bridge the gap between traditional clinical settings and home-based care, a critical requirement in the modern healthcare landscape. The company's technology stack is engineered to support complex medical workflows, ensuring that clinicians have access to actionable data that improves patient safety and operational efficiency.
How much funding has Current Health raised?
Current Health has raised a total of $54.5M across 2 funding rounds:
Series A
$11.5M
Series B
$43M
Series A (2019): $11.5M with participation from Par Equity, Scottish Investment Bank, Legal & General, and MMC Ventures
Series B (2021): $43M led by Northpond Ventures, Section 32, Elements Health Ventures, OSF HealthCare, and LRVHealth
Key Investors in Current Health
MMC Ventures
A venture capital firm that specializes in scaling technology companies from the Seed and Series A stages, focusing on transformative market solutions.
LRVHealth
A specialized venture capital firm dedicated to identifying and building disruptive companies within the digital health, medical device, and diagnostic sectors.
Section 32
A venture capital firm founded by Bill Maris that targets innovative startups and emerging technologies at the forefront of scientific and medical advancement.
What's next for Current Health?
With the recent influx of capital, Current Health is poised to deepen its penetration into the enterprise healthcare market. The strategic focus will likely shift toward scaling its remote patient monitoring platform to accommodate larger health systems and expanding its diagnostic capabilities. As the company matures, it will continue to leverage its partnerships with institutional investors to refine its business model and solidify its role as a foundational player in the digital health revolution. Future growth will be driven by the integration of advanced analytics and the continued optimization of its patient-centric technology suite, ensuring that the firm remains at the forefront of health tech innovation.
See full Current Health company page
